Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases
NL-OMON47208Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of floxuridine in colorectal cancer (CRC), sponsored by Erasmus MC. Primary endpoints: 90-day postoperative major complications and Successful administration of at least one HAIP chemotherapy cycle. Started Jan 2018; status: recruiting.
02
Drugs
floxuridine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NL-OMON47208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47208.